COLORADO SPRINGS - The United States Anti-Doping Agency has slapped American sprinter Wallace Spearmon with a three-month suspension after the US Olympian failed a drug test in July. The 29-year-old Spearmon tested positive for Methylprednisolone during an international track meet on July 6 in Edmonton, Canada. Spearmon claimed the anti-inflammatory drug was in a prescription he was taking and that he didn't know that it was on USADA's and the World Anti-Doping Agency's banned list. Spearmon could have asked for a therapeutic exemption to continue taking the drug but failed to do so. "After a thorough review of the case, including Spearmon's medical records, USADA has accepted Spearmon's explanation that the Methylprednisolone was not being used in an effort to enhance his performance."–AFP